Evidence map›Paper›PMID 39107673›Full record

ArticleDrug delivery and translational research2025

The topical application of Sphistin

Weiyi He, Chi Zhang, Huijung Lai, Guopeng Wu, Ming Xiong, Hui Peng, Ming Chen, Ke-Jian Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Weiyi He *Department of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China.
Chi Zhang *Department of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China.
Huijung Lai *Department of Dermatology Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China.
Guopeng WuPingtan Research Institute of Xiamen University, Pingtan, 350400, China.
Ming XiongDepartment of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China.
Hui PengDepartment of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China.
Ming ChenDepartment of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China. ming.chen@xmu.edu.cn.ORCID 0000-0002-8397-2184
Ke-Jian WangDepartment of Marine Biological Science & Technology, College of Ocean & Earth Sciences, Xiamen University, Xiamen, 361102, China. wkjian@xmu.edu.cn.

Funding

Fujian Ocean and Fisheries Department FJHJF-L-2019-1Guidance in Medical and Health Program of Xiamen. 3502Z20209114Pingtan Research Institute of Xiamen University Z20220743Pingtan Research Institute of Xiamen University Z20220791Xiamen Marine and Fisheries Development Fund 21CZP002HJ05Xiamen Marine and Fisheries Development Fund 22CZP002HJ08
6 · The paper itself

Abstract

We demonstrated for the first time that a marine-derived antimicrobial peptide (AMP), Sph

Indexed as

Acne VulgarisAnti-Bacterial AgentsAntimicrobial PeptidesPoriferaAdministration, CutaneousAdministration, TopicalAnimalsHumansKeratinocytesMicrobial Sensitivity TestsPropionibacterium acnesRabbitsAnti-Bacterial AgentsAntimicrobial PeptidesAcne vulgarisAntimicrobial peptidesSponge spiculesTopical delivery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.